Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05363371Not ApplicableActive Not Recruiting

Minds and Mentors Program- R33

Role: collaborator

NCT04233671Not ApplicableCompleted

Minds and Mentors Program (MiMP)- R61

Role: collaborator

NCT04893395Not ApplicableWithdrawn

Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans

Role: collaborator

NCT03543722Not ApplicableUnknown

Independence Project

Role: collaborator

NCT00641511Phase 2Withdrawn

Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

Role: collaborator

NCT01394081Not ApplicableCompleted

Alabama Veterans Rural Health Initiative

Role: collaborator

All 6 trials loaded